Engineering expertise plays a central role when working to meet the … [Read More...]
White Papers
Gain new perspective into the heightened scrutiny of medical device E&L
Recent feedback from several regulatory agencies has demonstrated increased … [Read More...]
Surgical device development: New insights from the operating room
Successful surgical device development is dependent on teasing out, … [Read More...]
New Requirements for Medical EMC: IEC 60601-1-2 Edition 4
Plan now to ensure your medical devices comply with new EMC requirements by … [Read More...]
Mergers & Acquisitions.
Catalent dishes out $950m for biologics manufacturer
Catalent said today that it plans to purchase Cook Pharmica for $950 million in cash. Cook Pharmica, a unit of privately-held medical device maker Cook Group, is a contract manufacturer that develops biologics-based drug compounds. Get the full story at our sister site, Drug Delivery Business News.
Another extension for Abbott’s tender for Alere
Abbott (NYSE:ABT) today announced yet another extension of its tender offer for all outstanding Alere (NYSE:ALR) Series B convertible perpetual preferred shares at $402 per share, pushing the deadline from Sept. 15. to near the end of the month. As part of the offering, Abbott said it will also pay for unpaid dividends to the settlement date of […]
Medtronic, Mazor Robotics close $40m round
Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in Mazor. The […]
LivaNova mulls sale for CRM biz
LivaNova (NSDQ:LIVN) said today that it’s considering a sale for its cardiac rhythm management business, tapping Barclays to shop the $250 million operation to potential buyers. “As part of our ongoing efforts to position LivaNova for long-term success, we are sharpening our focus on the company’s areas of strength and market leadership. To that end, we […]
Teva deals Paragard IUD assets to Cooper Cos. for $1B
Cooper Cos. (NYSE:COO) said today it inked a deal to purchase the Paragard intrauterine device assets and business, including a Buffalo, N.Y.-based factory, from Teva Pharmaceuticals (NYSE:TEVA) for $1.1 billion in cash. The deal has been unanimously approved by both Teva and The Cooper Co.’s boards of directors, and is expected to close prior to the end of 2017, […]
Integra LifeSciences deals $48m in neurosurgery assets to Natus Medical
Integra LifeSciences (NSDQ:IART) said today that it plans to deal some of its neurosurgery assets to Natus Medical (NSDQ:BABY) for nearly $48 million, contingent on the consummation of its $1 billion buyout of the Codman Neurosurgery business from Johnson & Johnson (NYSE:JNJ). Plainsboro, N.J.-based Integra said the sale to Natus includes its line of Camino intracranial […]
Broncus Medical affiliate acquires Uptake Medical
Uptake Medical said yesterday that its InterVapor device for treating emphysema is back on the market in Europe after its acquisition for an undisclosed amount by an affiliate of Broncus Medical. Broncus set its purchase up under a new entity based in Seattle, Uptake Medical Technology, and plans to add markets in Australia and Asia to […]
MassDevice Network
@MassDevice
LinkedIn
Google+